Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,370 | 21,340 | 33,760 | 15,980 | 13,410 |
| Marketable Securities | 23,460 | 17,530 | 8,530 | 14,510 | 19,820 |
| Other current assets | 350 | 300 | 240 | 110 | 140 |
| TOTAL | $37,180 | $39,170 | $42,530 | $30,600 | $33,370 |
| Non-Current Assets | |||||
| PPE Net | N/A | 960 | 960 | 950 | 950 |
| Other Non-Current Assets | 1,030 | 1,060 | 1,050 | 1,080 | 1,100 |
| TOTAL | $1,030 | $2,020 | $2,010 | $2,030 | $2,050 |
| Total Assets | $38,330 | $40,290 | $43,650 | $31,750 | $34,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 860 | 200 | 400 | 490 | 1,240 |
| Accrued Expenses | 2,970 | 2,260 | 2,370 | 2,120 | 2,020 |
| TOTAL | $3,830 | $2,460 | $2,780 | $2,620 | $3,270 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,830 | $2,460 | $2,780 | $2,620 | $3,270 |
| Shareholders' Equity | |||||
| Common Shares | 200 | 200 | 200 | 160 | 160 |
| Retained earnings | -98,570 | -95,130 | -92,070 | -90,040 | -87,790 |
| Other shareholders' equity | -2,600 | -300 | -480 | -510 | -680 |
| TOTAL | $34,500 | $37,830 | $40,870 | $29,130 | $31,280 |
| Total Liabilities And Equity | $38,330 | $40,290 | $43,650 | $31,750 | $34,550 |